Yield10 Bioscience Announces Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Yield10 Bioscience, Inc. (YTEN) Tops Q3 EPS by 16c
November 10, 2021 4:23 PM ESTYield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q3 EPS of ($0.49), $0.16 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $92 thousand versus the consensus estimate of $210 thousand.
For earnings history and earnings-related data on Yield10 Bioscience, Inc. (YTEN) click here.
... More